Insiders Trades
Xlife Sciences AG Stock: price and insider trades · Switzerland
4 insiders bought €132k of shares over the last 90 days, the latest filed 25 Sept 2026.
Cluster: 4 buyers in 30 daysXlife Sciences AG: what insiders have been doing
This page follows insider dealings at Xlife Sciences AG as filed with SIX SER based in Zurich, Switzerland. The last twelve months, up to 18 October 2026, brought 4 filings signed by 4 insiders.
Every open-market trade in the period is a purchase: 4 purchases worth €132k, from 4 insiders, and not a single sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The filings include the largest purchase, €33k, on 25 September 2026, which represents 0.052% of the company's market value. The buyers include 4 senior executives.
With 4 filings in twelve months, the company is quieter than the median of 9 filings across the 178 companies we follow on the same exchange. Since 2026, the database holds 4 purchases and no sales by insiders of the company.
The data flag 4 purchases as part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (25 September 2026) now reads 22 days.
These figures are compiled from regulatory filings published by SIX SER. They describe what insiders did and are not a recommendation.
Key facts
Headquarters: Zurich, Switzerland
Source: Wikidata (CC0).
Insider Decl.
4
Thresholds
n/a
Buy Volume
€131,512
4 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAnonymous (a non-executive member of the board of directors)1 buy
Anonymous (an executive member of the board of directors / member of senior management)1 buy
Anonymous (Executive member of the board of directors / member of senior management)1 buy
Anonymous (Non-executive member of the board of directors)1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 23,544 of 24,148 companies
11.4
score / 100
Value18
Quality5
FCF yld-2.2%
Earn yld-38%
EV/EBITDA·
ROE-64%
Gross mgn3.4%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CHF 9.36
Analyst consensus
1 analystsCHF 31.00Target CHF 31.00(+231%)CHF 31.00
Income statement
RevenueCHF 275.3k
Gross profitCHF 9.3k3% margin
EBITDA-CHF 3.1M-1109% margin
Net income-CHF 21.5M-7826.5% margin
Valuation
PER (forward)-3.2x
P/Book0.4x
Beta0.50
Balance sheet & cash
Market capCHF 54M
Total debtCHF 60M
Free Cash Flow-CHF 1.3M
Debt / Equity28%
Profitability & ownership
ROE-64.1%
ROA-4.5%
% insiders48.5%
% institutions5.3%
Last declaration on 25 September 2026
Declarations4 total
3,000 shares@ CHF 10.350.052% mcap100.0% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q9P00022
Canonical exit: 24 Dec 2026 (T+90)
▲
Anonymous (an executive member of the board of directors / member of senior management)
3,000 shares@ CHF 10.350.052% mcap100.0% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q9P00030
Canonical exit: 24 Dec 2026 (T+90)
3,000 shares@ CHF 10.35140.055% mcap100.0% of flowISIN CH0461929603SIX:T1Q9P00022
Canonical exit: 24 Dec 2026 (T+90)
▲
Anonymous (Executive member of the board of directors / member of senior management)
3,000 shares@ CHF 10.350.055% mcap100.0% of flowISIN CH0461929603SIX:T1Q9P00030
Canonical exit: 24 Dec 2026 (T+90)
4 of 4 declarations
About Xlife Sciences AG
Xlife Sciences AG is a company focused on developing innovative solutions in the life sciences sector. It is listed on the Swiss stock exchange XSWX.
